Updates on Management of Adult Medulloblastoma.
Opinion Statement: Medulloblastoma (MB) is a malignant embryonal tumor of the posterior fossa and is the most common type of brain cancer in pediatric patients. In contrast, adult MB is very rare with an incidence of 0.6 per million per year and mostly affects young adults below the age of 40. Recen...
| Published in: | Current Treatment Options in Oncology Vol. 20; no. 8 |
|---|---|
| Main Authors: | , |
| Format: | research Journal Article |
| Published: |
Springer Nature
Aug2019
|
| Online Access: | View this record in EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=137471979&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 137471979 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 15272729 3KHC jtl: Current Treatment Options in Oncology issn: 15272729 maglogo: N pubinfo: dt: Aug2019 vid: 20 iid: 8 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 137471979 137471979 NLM31236711 137471979 10.1007/s11864-019-0663-0 NLM31236711 137471979 ppct: 1 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Updates on Management of Adult Medulloblastoma. aug: au: Majd, Nazanin Penas-Prado, Marta affil: MD Anderson Cancer Center Department of Neuro-oncology, 1515 Holcombe Blvd., 77030, Houston, TX, USA sug: subj: Brain Neoplasms Diagnosis Glioma Diagnosis Glioma Therapy Brain Neoplasms Therapy Combined Modality Therapy Diagnostic Imaging Glioma Etiology Neoplasm Metastasis Glioma Mortality Human Brain Neoplasms Etiology Brain Neoplasms Mortality Disease Management Clinical Trials Neoplasm Staging Treatment Outcomes Neoplasm Grading Scales ab: Opinion Statement: Medulloblastoma (MB) is a malignant embryonal tumor of the posterior fossa and is the most common type of brain cancer in pediatric patients. In contrast, adult MB is very rare with an incidence of 0.6 per million per year and mostly affects young adults below the age of 40. Recent molecular analyses of pediatric and adult MB have classified these tumors into at least four individual molecular subgroups (SHH, WNT, group 3, and group 4) with distinct demographics, histology, and prognosis. The discrete biological composition of these tumors likely explains the marked heterogeneity in responses seen to conventional therapies such as radiation and cytotoxic chemotherapies. Given the low incidence of adult MB, prospective studies are challenging and scarce, and management guidelines are largely derived from the pediatric MB patient population and retrospective data. However, adult MB is clinically and molecularly distinct from pediatric MB and a comprehensive review of published literature on adult MB highlighting their differences is warranted. Here, we review the management of adult MB focusing on recent studies exploring the effectiveness of upfront chemotherapy, clinical trials in the context of molecular subgroup-specific therapies, and the potential role of immunotherapy in treating this disease. pubtype: Academic Journal doctype: research Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|